Specialty & Oncology February 2020

Oral Targeted Therapies for B-Cell Lymphomas

Over the last two decades, the discovery of novel signaling pathways in B-cell lymphoid malignancies has fueled the development of new drug therapies.

The Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia

Direct oral anticoagulants have recently emerged as a potential option for the management of HIT.

Continuing Education

$6.97 Per CE Exam or $59 for 12 Lessons